BrightFocus proudly supports over 200 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
BrightFocus Editorial Staff
BrightFocus Foundation’s 2024 research portfolios highlight the active biomedical research projects the Foundation is supporting across the globe to advance cures for Alzheimer’s disease, macular degeneration, and glaucoma.
These projects are rigorously selected by a committee of world-renowned scientists who serve on the Foundation’s Scientific Review Committees to reflect the most innovative and promising ideas that will advance our understanding of these diseases of mind and sight.
BrightFocus is deeply grateful to its donors, whose generosity empowers the next generation of researchers to pursue innovative, bold, and promising science, bringing us closer to novel treatments, prevention strategies, and cures for Alzheimer’s disease, macular degeneration, and glaucoma.
Alzheimer’s Disease Research is supporting 112 grants examining the disease’s onset, progression, and treatments.
View the Alzheimer’s Disease Research Portfolio in magazine format or view a printable format (PDF).
Macular Degeneration Research is supporting 49 grants exploring the root causes and potential prevention, treatment, and cure of macular degeneration.
View the Macular Degeneration Research Portfolio in magazine format or view a printable format (PDF).
National Glaucoma Research is supporting 38 grants exploring the root causes and prevention strategies and treatments to end glaucoma.
View the National Glaucoma Research Portfolio in magazine format or view a printable format (PDF).
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research— the Foundation has awarded nearly $300 million in groundbreaking research funding over the past 51 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
BrightFocus Foundation’s 2024 annual report highlights groundbreaking research and public awareness efforts over the last year to defeat Alzheimer’s disease, macular degeneration, and glaucoma.
Global brain and vision research nonprofit BrightFocus Foundation has appointed three industry leaders to its board of directors.
BrightFocus Foundation hosted its inaugural Concert for Cures on Wednesday, June 26, at City Winery in Nashville.
BrightFocus Foundation has appointed Dr. Adam Myers as a new member of its board of directors.
